Cellectar Biosciences and LegoChemBio, a clinical-stage biotechnology company in South Korea, have entered a development and commercialization collaboration, the company announced today. According to a release, the two companies have…
Cellectar Biosciences has received another patent by the Japanese Patent Office, this time for its proprietary phospholipid-ether (PLE), the company announced today. According to a release, the patent provides composition…
The European Commission has granted Cellectar Biosciences orphan drug designation and 10 years of European market exclusivity for CLR 131 in Waldenstrom’s Macroglobulinemia (WM), the company announced today. “Receipt of European orphan…
Cellectar Biosciences has started a trial for CLR 131 in Waldenstrom’s macroglobulinemia (WM), the company announced recently. According to a release, the trial will include 50 WM patients who will…
Cellectar Biosciences announced today the pricing of its underwritten public offering of its common stock at $1.35 per share, which will result in gross proceeds of approximately $24.5 million. Cellectar also…
Cellectar Biosciences today announced the effective prices of $1.15 per share of common stock and one-half of a Series H Warrant of an underwritten public offering to raise approximately $20…
Cellectar Biosciences announced today that it has received a European patent for the composition of matter and use protection for the treatment and/or diagnosis of cancer and cancer stem cells for…
Cellectar Biosciences has been granted orphan drug designation for CLR 131 in Lymphoplasmacytic Lymphoma (LPL) by the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development, the company…
Cellectar Biosciences announced today it has entered into definitive agreements with institutional investors to purchase approximately $5 million in a registered direct offering of 1,982,000 common shares and approximately $5…
Cellectar Biosciences has received a patent for CLR 131 by the Japan Patent Office, the company announced recently. “Certain cancers such as pediatric lymphomas and leukemias have a higher prevalence…
